Physical Pharmacy and Formulation
A section of Pharmaceutics (ISSN 1999-4923).
Section Information
Physical Pharmacy and Formulation Section
This section is intended to rapidly publish all aspects of current issues in physicochemical characterization of drug substances including proteins, and their formulation design and products development. An example of specific topics includes but not limited to:
Physical Pharmacy
- Solubility
- Solubilization
- Dissolution
- Polymorphism
- Permeability
- Stability and stabilization
- New materials for controlling drug characteristics
- Analytical techniques
Formulation
- Novel excipients
- Formulation science
- Drug delivery systems
- Controlled release
- Drug targeting
- Bioavailability
- Quality-by-design
- Regulatory science
Editorial Board
Topic Board
Special Issues
Following special issues within this section are currently open for submissions:
- Lipidic Mesophases and Their Nano-Dispersions: An Emerging Drug Delivery Platform (Deadline: 20 September 2021)
- Biodegradable Polymers for Pharmaceutical Applications (Deadline: 20 September 2021)
- Solid Multicomponent Systems: Continuous Manufacturing Approaches for Improved Drug Product Quality (Deadline: 20 October 2021)
- Feature Papers in Physical Pharmacy and Formulation (Deadline: 20 October 2021)
- Formulations of Natural Origin and Synthetic Derivatives for the Treatment of Multi-Resistant Microorganisms (Deadline: 30 October 2021)
- Non-invasive Delivery of Biologics: Formulation Strategies and Regulatory Aspects (Deadline: 31 October 2021)
- Biosurfactants as Multifunctional Ingredients for Emerging Pharmaceutical Formulations (Deadline: 31 October 2021)
- Effects of Excipients in Oral Drug Absorption (Deadline: 31 October 2021)
- Recent Development in the Design and Manufacture of Amorphous Drug Formulations (Deadline: 31 October 2021)
- Discovery and Evaluation of Novel Adjuvants for Vaccine Formulations (Deadline: 10 November 2021)
- Cocrystal Applications in Drug Delivery (Volume II) (Deadline: 20 November 2021)
- Drug-Loaded Carriers for the Treatment of Inflammatory Diseases (Deadline: 20 November 2021)
- New Formulations for Cancer Therapy Volume II (Deadline: 20 November 2021)
- New Formulation for Acute and Chronic Inflammatory Diseases (Deadline: 30 November 2021)
- Therapeutic Formulations of Repurposed Drugs against COVID-19 (Deadline: 30 November 2021)
- Stability and Dissolution Behavior of Pharmaceutical Cocrystals (Deadline: 30 November 2021)
- ODX Formulations for Drug Delivery and Other Approaches to Overcome Swallowing Problems (Deadline: 30 November 2021)
- Medication Adherence Assessed with Real-World Data: New Opportunities Provided by Big Data (Deadline: 3 December 2021)
- Multidisciplinary Pharmaceutical Research for Improving Access to Essential Medicines (Deadline: 10 December 2021)
- Pharmaceutical Formulations with Antimicrobial Properties (Deadline: 10 December 2021)
- Phytopharmaceutical Technology (Deadline: 20 December 2021)
- Controlled Delivery Formulations (Volume II) (Deadline: 20 December 2021)
- New Developments in Pediatric Drug Formulations (Deadline: 30 December 2021)
- Wound Care: From Traditional Cotton Wound Dressings to Innovative Wound Dressings (Deadline: 30 December 2021)
- Nanomedicine Formulations Based on PLGA Nanoparticles for Diagnosis, Monitoring and Treatment of Disease: From Bench to Bedside (Deadline: 30 December 2021)
- Impact of Physicochemical Properties of Pharmaceutical Substances on Dosage Form Performance (Deadline: 31 December 2021)
- New Perspectives for the Administration of Cannabis for Medical Use: From Traditional to Advanced Formulations. What Next? (Deadline: 31 December 2021)
- Commemorative Issue in Honor of Professor Guy Van den Mooter (Deadline: 31 December 2021)
- Dissolution and Disintegration of Oral Solid Dosage Forms (Deadline: 20 January 2022)
- In Vivo Predictive Dissolution (iPD): Experimental and Mathematical Approaches and Regulatory Applications (Deadline: 20 January 2022)
- Novel Oligonucleotide Therapeutics and Their Delivery (Deadline: 30 January 2022)
- Microporous and Mesoporous Materials and Their Derived Hybrids as Systems for Controlled Release (Deadline: 10 February 2022)
- Nanomaterials and Novel Biologics to Manage Bacterial Infections (Deadline: 20 February 2022)
- Essential Oils in Pharmaceutical Products (Deadline: 30 March 2022)
Topical Collection
Following topical collection within this section is currently open for submissions: